484 studies found for:    Open Studies | "Anticoagulants"
Show Display Options
Rank Status Study
1 Recruiting START-Register: Survey on Anticoagulated Patients Register
Conditions: Atrial Fibrillation;   Venous Thromboembolism;   Heart Valve Diseases or Prosthesis;   Other Heart or Peripheral Vascular Diseases Leading to Chronic Anticoagulation
Interventions: Drug: Anticoagulants;   Drug: anticoagulants
2 Not yet recruiting Influence of ABCB1 Polymorphisms on Plasma Concentrations of New Oral Anticoagulants in Case of Serious Adverse Events
Conditions: Anticoagulants;   Thromboembolism;   Hemorrhage
Interventions: Other: Measurement of Plasma Concentrations of NOACs;   Genetic: Identification of ABCB1 polymorphisms coding for P-gp
3 Recruiting Evaluation of the Duration of Therapy for Thrombosis in Children
Condition: Venous Thrombosis
Interventions: Other: Shortened duration (6 weeks) of anticoagulant therapy;   Other: Conventional duration (3 months) of anticoagulant therapy;   Other: No Intervention
4 Not yet recruiting SILENT - Subclinical AtrIal FibrilLation and StrokE PreveNtion Trial
Condition: Atrial Fibrillation
Intervention: Drug: anticoagulant by physician criteria
5 Recruiting Patent Foramen Ovale Closure or Anticoagulants Versus Antiplatelet Therapy to Prevent Stroke Recurrence
Conditions: Ischemic Stroke;   Patent Foramen Ovale;   Atrial Septal Aneurysm;   Migraine
Interventions: Drug: aspirin;   Drug: Antivitamins K;   Device: Devices for PFO closure
6 Recruiting Rhythm Evaluation for AntiCoagulaTion With COntinuous Monitoring
Condition: Atrial Fibrillation
Intervention: Drug: Non-coumadin Oral Anticoagulant
7 Not yet recruiting Evaluation of the Use of Apixaban in Prevnetion of Thromboembolic Disease in Patients With Myeloma Trated With iMiDs
Conditions: Myeloma;   Venous Thromboembolism
Intervention: Drug: Apixaban
8 Recruiting Clinical Decision Rule Validation Study to Predict Low Recurrent Risk in Patients With Unprovoked Venous Thromboembolism
Condition: Idiopathic Venous Thromboembolism
Intervention: Other: Application of the"Men continue and HER DOO2" rule
9 Unknown  Anticoagulant Treatments and Percutaneous Coronary Angioplasty
Condition: Coronary Artery Disease
Interventions: Drug: clopidogrel + aspirin;   Drug: heparin + clopidogrel + aspirin;   Drug: enoxaparin + clopidogrel + aspirin;   Drug: bivalirudin + clopidogrel + aspirin
10 Recruiting Outpatient Treatment of Low-Risk Venous Thromboembolism With Target Specific Anticoagulant
Condition: Venous Thromboembolism
Intervention:
11 Recruiting Benefits of a Comprehensive Patient Education on Oral Anticoagulant Compared to Conventional Hospital Education
Condition: Cardiac Surgery
Interventions: Behavioral: VKA (antivitamin K) education;   Behavioral: conventional hospital education
12 Recruiting Observatory of Invasive Procedures and Bleeding in Patients Treated With New Oral Anticoagulants
Conditions: Venous Thromboembolism;   Atrial Fibrillation
Intervention: Other: complications and compliance with GIHP recommendations
13 Unknown  Reversal of the Antithrombotic Action of New Oral Anticoagulants
Conditions: Thrombosis;   Anticoagulant-induced Bleeding;   Anticoagulant Overdosage;   Hemorrhage
Interventions: Drug: Rivaroxaban;   Drug: Dabigatran
14 Recruiting Therapy With New Oral Anticoagulants
Conditions: Atrial Fibrillation;   Non-valvular Atrial Fibrillation
Intervention:
15 Recruiting Accuracy of a Portable International Normalized Ratio Monitor in Elderly Patients
Conditions: Blood Coagulation Disorders;   Blood Coagulation Disorder With Prolonged Bleeding Time;   Blood Coagulation Disorder With Prolonged Coagulation Time
Interventions: Device: INR capillary measurement with INRatio 2 device;   Other: antiphospholipid antibodies and lupus anticoagulant
16 Unknown  rFVIIa in ICH in Patients Treated With Anticoagulants or Anti-Platelets
Condition: Intracerebral Hemorrhage
Interventions: Drug: rFVIIa + (vit K in AO patients);   Drug: FFP or aPCC+ vit K in AO treated patients
17 Recruiting Perioperative Anticoagulant Use for Surgery Evaluation Study
Condition: Atrial Fibrillation
Intervention:
18 Recruiting Reversal Agent Use in Patients Treated With Direct Oral Anticoagulants or Vitamin K Antagonists
Conditions: Severe Bleeding;   Urgent Surgery
Intervention:
19 Recruiting Study Of The Blood Thinner, Apixaban, For Patients Who Have An Abnormal Heart Rhythm (Atrial Fibrillation) And Expected To Have Treatment To Put Them Back Into A Normal Heart Rhythm (Cardioversion)
Condition: Atrial Fibrillation
Interventions: Drug: Apixaban;   Drug: Parenteral heparin and/or oral Vitamin K antagonist
20 Unknown  Monitoring Anticoagulant Therapy in Antiphospholipid Syndrome
Condition: Antiphospholipid Syndrome
Intervention:

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years